Quantcast
Last updated on April 16, 2014 at 6:49 EDT

Latest Methylphenidate Stories

2013-11-27 16:25:22

TORONTO, Nov. 27, 2013 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), an emerging pharmaceutical company, today announced that the Company's President and Chief Executive Officer, David Lickrish, will present at the 25(th) Annual Piper Jaffray Healthcare Conference at the New York Palace Hotel in New York City. Highland's presentation is scheduled for Wednesday, December 4, 2013 at 2:10pm EST. A live webcast of the presentation can be accessed by visiting...

2013-11-20 08:29:40

Company Launches with 180 Days Marketing Exclusivity for 15 mg Strength WOODCLIFF LAKE, N.J., Nov. 20, 2013 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has begun shipping dexmethylphenidate hydrochloride (HCl) 15 mg and 30 mg extended-release (ER) capsules CII following approval by the U.S. Food and Drug Administration. As marketer and distributor, Par will have 180 days of marketing exclusivity for the 15 mg strength and will share profits with its...

Monkey Sense Without Seeing
2013-11-20 08:05:54

redOrbit Staff & Wire Reports - Your Universe Online The human ability to locate and avoid objects in their peripheral field of vision with little more than a sideways glace could also be present in monkeys, according to new research in the journal Animal Cognition. Lau Andersen of the Aarhus University in Denmark and his colleagues trained five adult male rhesus monkeys in order to perform a short-latency, highly stereotyped localization task. They taught the creatures to touch...

2013-11-18 08:28:12

- Company awarded 180 days marketing exclusivity - PITTSBURGH, Nov. 18, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Dexmethylphenidate Hydrochloride Extended-release (ER) Capsules, 30 mg, which is the first generic version of Novartis' Focalin XR(®). Mylan was the first company to have filed a substantially complete Abbreviated New Drug Application (ANDA) containing a Paragraph IV patent certification for...

2013-11-14 13:03:08

One in seven Swiss students has already tried to enhance his or her performance with prescription medication or drugs. Besides psychostimulants like Ritalin, students also consume sedatives, alcohol or cannabis. These substances are mostly only taken during the exam preparation period. Only a narrow majority of polled students reported the desired effects, as a representative study conducted by researchers at the universities of Zurich and Basel reveals. American and European studies prove...

ADHD Drug Ritalin Shown To Control Impulsiveness In Rhesus Monkeys
2013-11-14 07:30:27

redOrbit Staff & Wire Reports - Your Universe Online Impulsive monkeys were more likely to accept delayed gratification after being given a dose of methylphenidate, the active ingredient of the drug Ritalin, according to new research presented during Neuroscience 2013, the annual meeting of the Society for Neuroscience. According to Luis Populin, associate professor of neuroscience at University of Wisconsin-Madison, 11 percent of all American children between the ages of four and...

2013-11-05 04:23:21

DUBLIN, November 5, 2013 /PRNewswire/ -- Shire Plans to Submit a Supplemental New Drug Application (sNDA) by Q3 2014 Shire plc (LSE: SHP, NASDAQ: SHPG) announces positive top-line results from two identically designed randomized placebo-controlled Phase 3 studies evaluating the efficacy and safety of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules (CII) versus placebo in adults with binge eating disorder (BED). In both studies Vyvanse was found to be statistically...

2013-10-15 11:55:31

People with ADHD and substance dependence rarely respond as they should to ADHD medication. A randomized study from Karolinska Institutet now shows that it is possible to obtain the desired efficacy by administering the drug in higher doses. The results of the study are published in the scientific journal Addiction. ADHD is much more common in people who use drugs than in the population at large. ADHD can be treated with methylphenidate, a CNS stimulant used for both children and adults....

2013-10-03 12:25:48

TORONTO, Oct. 3, 2013 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), a specialty pharmaceutical company leveraging its proprietary technologies to optimize the delivery of previously approved drug products, today announced that its wholly owned subsidiary has generated positive interim Phase I/II results from an ongoing study of HLD-200 - a novel formulation of methylphenidate being developed to treat the symptoms associated with Attention-Deficit/Hyperactivity Disorder...

2013-08-30 23:25:34

The new school year can bring stress and anxiety that pushes college students to use drugs or alcohol. Fort Lauderdale, Florida (PRWEB) August 30, 2013 Going back to school can be an exciting time for students and parents but it isn’t without a few dangers. Destination Hope, a nationally renowned addiction treatment center in South Florida, is reminding families to be aware of the potential for drug and alcohol abuse among college students. Data indicates that 45 percent of college...